drugset / Trial / NCT02281006

Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity

NCT02281006

Phase 2 Terminated 13 enrolled CHU de Quebec-Universite Laval
RandomizedParallel-groupSingle-blindSupportive care

Summary

This study evaluates whether a gel containing sodium thiosulfate deposited via a trans-tympanic injection on the round window of the middle ear could reduce the ototoxicity caused by the drug Cisplatin among patients with head and neck cancer treated by chemoradiation. One ear selected randomly will be treated while the other will serve as control.

Timeline

Start
2015-01-01
Primary completion
2017-01-20
Completion
2017-01-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Thiosulfate Diagnostic / imaging agent 0.1 ml Other

Indications